Clinical Trials Directory

Trials / Conditions / Stargardt's Macular Dystrophy

Stargardt's Macular Dystrophy

7 registered clinical trials studyying Stargardt's Macular Dystrophy.

StatusTrialSponsorPhase
CompletedZimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
NCT03364153
Astellas Pharma Global Development, Inc.Phase 2
UnknownClinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in
NCT02749734
Southwest Hospital, ChinaPhase 1 / Phase 2
CompletedA Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic S
NCT02941991
Astellas Institute for Regenerative Medicine—
CompletedSafety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)
NCT01625559
CHABiotech CO., LtdPhase 1
CompletedLong Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Pa
NCT02445612
Astellas Institute for Regenerative Medicine—
CompletedSafety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented
NCT01469832
Astellas Institute for Regenerative MedicinePhase 1 / Phase 2
CompletedSub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
NCT01345006
Astellas Institute for Regenerative MedicinePhase 1 / Phase 2